May 2026 in “Ibero-American Journal of Health Science Research” Regenerative therapies like PRP and stem cells are promising for skin rejuvenation and repair.
Genetics and hormones cause hair loss in women, treatable with drugs and new therapies.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Genetics and hormones cause hair loss in women, treatable with drugs and new therapies.
April 2026 in “Science & Justice” Hair analysis can confirm drug use but can't accurately measure how much was taken.
April 2026 in “Frontiers in Pharmacology” Erzhi Pill shows promise for health issues but needs better quality control and clearer usage guidelines.
Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific doses and precautions.
Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific doses and precautions.
Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific doses and precautions.
January 2026 in “Clinical Cosmetic and Investigational Dermatology” Polynucleotides show promise for improving skin conditions safely but need more research.
December 2025 in “Zagazig University Medical Journal” PDO threads may help regrow hair and increase thickness in hair loss.
November 2025 in “Current Cosmetic Science” Rosemary may help prevent hair loss and promote hair growth, but more research is needed.
October 2025 in “Bioengineering” Coating surgical meshes with PRP may improve hernia repair outcomes.
September 2025 in “International Journal of Innovative Technologies in Social Science” Low-dose oral minoxidil is effective and safe for hair loss, but more research is needed.
August 2025 in “Medicine and ecology” Adipose tissues and platelet-rich plasma help tissue repair and healing in surgery.
July 2025 in “The Lancet Regional Health - Southeast Asia” New guidelines and referral pathways for skin conditions aim to improve care and referrals in Pakistan.
April 2025 in “Journal of Medical Residency Review” PRP combined with other treatments shows promise for skin rejuvenation.
February 2025 in “International Journal of Advanced Research in Science Communication and Technology” Fenugreek seeds may improve hair health and growth.
August 2024 in “Stem Cell Research & Therapy” New regenerative therapies show promise for treating hair loss.
August 2024 in “Quality in Sport” PRP helps with skin, hair, and wound treatments but needs more research for standard use.
August 2024 in “Skin Research and Technology” PRP is an effective and safe treatment for female hair loss.
April 2024 in “Vestnik dermatologii i venerologii” Exosomes show promise for diagnosing and treating skin conditions and hair loss.
March 2024 in “Journal of Experimental & Biomedical Sciences/Biomedical Science Letters” BCC can protect heart cells from damage caused by oxidative stress.
March 2024 in “Indian Journal of Dermatology/Indian journal of dermatology” Exosomes could be key in treating skin conditions and healing wounds.
September 2023 in “Journal of Education, Health and Sport” PRP shows promise for skin and hair treatments but needs more research to confirm its effectiveness.
September 2023 in “Brazilian Journal of Health Review” COVID-19 may cause a common type of hair loss called telogen effluvium.
October 2022 in “Hair Transplantation” New punch designs for hair transplants have expanded options for surgeons.
May 2022 in “Hair transplant forum international” The document concludes that following a specific 15-step process can improve the success of hair transplant extractions.
January 2022 in “Clinical Cases in Dermatology” Hypothyroidism can cause hair loss, which is often reversible with treatment.
PRP is a safe, low-cost treatment used in dermatology for hair loss, skin rejuvenation, scar repair, and wound healing.
June 2017 in “Experimental dermatology” Skin has a larger surface area than thought, certain skin cells improve skin flap survival, better trials for skin conditions in children are needed, Stevens-Johnson syndrome rates vary by age and race, and better skin barrier function may reduce inflammation in the elderly.